Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2023-09-18
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Covid-19 in Lupus Patients
NCT04355702
Immunoadsorption in Autoimmune Long COVID
NCT07316127
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
NCT06928272
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
NCT04397237
Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persons with- long-covid
Women and men diagnosed with persistent COVID according to WHO (World HEalth Organization) criteria: persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treated at the Parc Taulí Hospital
* from 18 to 65 years
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitat Autonoma de Barcelona
OTHER
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Selva
Co-principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Selva, MD, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Parc Taulí, Hospital Universitari- I3PT
Juan Leiva, PhD
Role: STUDY_DIRECTOR
Universitat Autònoma Barcelona
Pilar Peña, MD
Role: PRINCIPAL_INVESTIGATOR
Parc Taulí, Hospital Universitari- I3PT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Pilar Peña, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LONGCOVID EXPERIENCE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.